- SynonymsN-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-N-(2-((4-(1-((2S,3R)-2-hydroxypentan-3-yl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)phenyl)amino)ethyl)formamide
- Description
N-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-N-(2-((4-(1-((2S,3R)-2-hydroxypentan-3-yl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)phenyl)amino)ethyl)formamide
Posaconazole Impurity 14 (POS-I) is a fully characterized chemical compound used as a reference standard of API Posaconazole. The standard offered is compliant with regulatory guidelines. Posaconazole Impurity 14 (POS-I) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
Related products
Posaconazole Impurity 25 Oxalate

M.F.
M.W. 236.32 90.03
CAT# AR-P02385
CAS# 1428118-40-4 (free base)